ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

Page 2: The Debate Over Brigham’s Containment Bag Study

November 21, 2014

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

Statistics Review Shows Improved Mortality Under 65, Through 1986

January 19, 1990

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

President to Propose 2 Percent Increase in NIH Budge, Slowing Funding Growth

January 15, 1999